GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Taiyen Biotech Co Ltd (TPE:1737) » Definitions » 5-Year EBITDA Growth Rate

Taiyen Biotech Co (TPE:1737) 5-Year EBITDA Growth Rate : -0.40% (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Taiyen Biotech Co 5-Year EBITDA Growth Rate?

Taiyen Biotech Co's EBITDA per Share for the three months ended in Dec. 2024 was NT$0.80.

During the past 12 months, Taiyen Biotech Co's average EBITDA Per Share Growth Rate was 24.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -2.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -0.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Taiyen Biotech Co was 47.10% per year. The lowest was -24.00% per year. And the median was 3.60% per year.


Competitive Comparison of Taiyen Biotech Co's 5-Year EBITDA Growth Rate

For the Household & Personal Products subindustry, Taiyen Biotech Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiyen Biotech Co's 5-Year EBITDA Growth Rate Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Taiyen Biotech Co's 5-Year EBITDA Growth Rate falls into.


;
;

Taiyen Biotech Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Taiyen Biotech Co  (TPE:1737) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Taiyen Biotech Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Taiyen Biotech Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiyen Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 297, Section 1, Chien-Kang Road, South District, Tainan, TWN
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.

Taiyen Biotech Co Headlines

No Headlines